Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
Hemant Surgical Industries Lim | NA | NA | NA | NA | 209.0 | 25.7 |
CORAL LABORATORIES LTD. | 306.16 | 28.27 | 281.35 | 7.91 | 207 | 8.37 |
PHARMAIDS PHARMACEUTICALS LTD. | 11.39 | -30.56 | 1.33 | -0.86 | 204 |
Hemant Surgical Industries Limited, with Security Code 543916, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Sep 2023 |
---|---|
Sales | 47.5 |
Expenses | 44.4 |
Operating Profit | 3.1 |
OPM % | 6.56% |
Other Income | 2.6 |
Interest | 0.5 |
Depreciation | 0.5 |
Profit before tax | 4.7 |
Tax % | -17.1% |
Net Profit | 3.9 |
EPS in Rs | 4.15 |
No Consolidated data available.
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 14% |
3 Years: | 21% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 54% |
3 Years: | 93% |
TTM: | -2% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | -25% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | 0% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
---|